Abstract
There is no consensus regarding the impact of polycystic ovary syndrome (PCOS) and its hormonal profile on sexual function of affected women; majority of data documented are not population based and there is a lack of studies investigating the association between hormonal profiles with sexual function in women with PCOS. We aimed to compare the sexual function of PCOS women with controls in a population-based study based on their hormonal profiles. In this cross-sectional study, sexual function (using the Female Sexual Function Index (FSFI) questionnaire) and hormonal profiles were determined in 63 PCOS subjects and 216 healthy women (controls); aged 18–45 years. A comparison of PCOS women and controls showed no statistically significant difference in total FSFI and each of its specific domain scores. There were significant positive correlations between dehydroepiandrosterone sulfate and total FSFI, orgasm and satisfaction domains in controls (r=0.156, r=0.206, r=0.275, respectively). No significant correlations between hormonal profiles and FSFI scores were found in the PCOS group, except for prolactin and orgasm (r=−0.250). In conclusion, sexual function did not differ between PCOS women and controls. High levels of androgens in women with PCOS were not associated with an improvement in sexual function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aslan E, Fynes M . Female sexual dysfunction. Int Urogynecol J 2008; 19: 293–305.
Meston CM, Bradford A . Sexual dysfunctions in women. Annu Rev Clin Psychol 2007; 3: 233–256.
Witting K, Santtila P, Rijsdijk F, Varjonen M, Jern P, Johansson A et al. Correlated genetic and non-shared environmental influences account for the co-morbidity between female sexual dysfunctions. Psychol Med 2009; 39: 115–127.
Berman JR, Goldstein I . Female sexual dysfunction. Urol Clin N Am 2001; 28: 405–416.
Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB . Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112: 970–978.
Fugl-Meyer KS, Arrhult H, Pharmanson H, Backman AC, Fugl-Meyer AM, Fugl-Meyer AR . A Swedish telephone help-line for sexual problems: a 5-year survey. J Sex Med 2004; 1: 278–283.
Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17: 39–57.
Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–544.
Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y . Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 2008; 139: 59–64.
March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ . The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544–551.
Peppard HR, Marfori J, Iuorno MJ, Nestler JE . Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 2001; 24: 1050–1052.
Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF, Dunaif A . Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res 1998; 53: 217–256.
Abbott DH, Barnett DK, Bruns CM, Dumesic DA . Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005; 11: 357–374.
Buggs C, Rosenfield RL . Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin N Am 2005; 34: 677–705.
Vutyavanich T, Khaniyao V, Wongtra-Ngan S, Sreshthaputra O, Sreshthaputra R, Piromlertamorn W . Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women. J Obstet Gynaecol Res 2007; 33: 677–680.
Veras AB, Bruno RV, de Avila MA, Nardi AE . Sexual dysfunction in patients with polycystic ovary syndrome: clinical and hormonal correlations. Compr Psychiatry 2011; 52: 486–489.
Himelein MJ, Thatcher SS . Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006; 61: 723–732.
Jones GL, Hall JM, Balen AH, Ledger WL . Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update 2008; 14: 15–25.
Ercan CM, Coksuer H, Aydogan U, Alanbay I, Keskin U, Karasahin KE et al. Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome. Int J Impot Res 2013; 25: 127–132.
Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 5801–5807.
Kitzinger C, Willmott J . The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med 2002; 54: 349–361.
Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R et al. Association of body weight with sexual function in women. Int J Impot Res 2007; 19: 353–357.
Trent ME, Rich M, Austin SB, Gordon CM . Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol 2003; 16: 33–37.
Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F . Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One 2015; 10: e0123608.
Hashemi S, Ramezani Tehrani F, Farahmand M, Bahri Khomami M . Association of PCOS and its clinical signs with sexual function among Iranian women affected by PCOS. J Sex Med 2014; 11: 2508–2514.
De Niet J, De Koning C, Pastoor H, Duivenvoorden H, Valkenburg O, Ramakers M et al. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 2010; 25: 1497–1503.
Eftekhar T, Sohrabvand F, Zabandan N, Shariat M, Haghollahi F, Ghahghaei-Nezamabadi A . Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains. Iran J Reprod Med 2014; 12: 539.
Stovall DW, Scriver JL, Clayton AH, Williams CD, Pastore LM . Sexual function in women with polycystic ovary syndrome. J Sex Med 2012; 9: 224–230.
Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S . Sexual functioning among married Iranian women with polycystic ovary syndrome. Int J Fertil Steril 2014; 8: 273–280.
Janssen OE, Hahn S, Tan S, Benson S, Elsenbruch S . Mood and sexual function in polycystic ovary syndrome. Semin Reprod Med 2008; 26: 45–52.
Davis SR, McCloud P, Strauss BJ, Burger H . Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227–236.
Somboonporn W, Davis S, Seif MW, Bell R . Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005; 19: CD004509.
Knapp R, Neff BD . Steroid hormones in bluegill, a species with male alternative reproductive tactics including female mimicry. Biol Lett 2007; 3: 628–631.
van Anders SM, Goldey KL . Testosterone and partnering are linked via relationship status for women and 'relationship orientation' for men. Horm Behav 2010; 58: 820–826.
Wingfield JC, Lynn S, Soma KK . Avoiding the 'costs' of testosterone: ecological bases of hormone-behavior interactions. Brain Behav Evol 2001; 57: 239–251.
Krapf JM, Simon JA . The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas 2009; 63: 213–219.
Braunstein GD . Safety of testosterone treatment in postmenopausal women. Fertil Steril 2007; 88: 1–17.
Anger JT, Brown AJ, Amundsen CL . Sexual dysfunction in women with polycystic ovary syndrome: the effects of testosterone, obesity, and depression. Female Pelvic Med Reconstr Surg 2007; 13: 119–124.
Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F . The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 2011; 9: 1477–7827.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191–208.
Mezones-Holguin E, Cordova-Marcelo W, Lau-Chu-Fon F, Aguilar-Silva C, Morales-Cabrera J, Bolanos-Diaz R et al. Association between sexual function and depression in sexually active, mid-aged, Peruvian women. Climacteric 2011; 14: 654–660.
Eggers S, Kirchengast S . The polycystic ovary syndrome—a medical condition but also an important psychosocial problem. Coll Antropol 2001; 25: 673–685.
Kowalczyk R, Skrzypulec-Plinta V, Nowosielski K, Lew-Starowicz Z . Sexuality in women with polycystic ovary syndrome. Ginekol Pol 2015; 86: 100–106.
Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S . Sexual functioning among married Iranian women with polycystic ovary syndrome. Int J Fertil Steril 2014; 8: 273–280.
March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ . The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544–551.
Acknowledgements
We acknowledge Niloofar Shiva for critical editing of English grammar and syntax of the manuscript. This work was supported by Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Noroozzadeh, M., Tehrani, F., Mobarakabadi, S. et al. Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study. Int J Impot Res 29, 1–6 (2017). https://doi.org/10.1038/ijir.2016.35
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2016.35
This article is cited by
-
Association of hirsutism and anthropometric profiles with sexual dysfunction and anxiety levels in infertile Indonesian women with polycystic ovarian syndrome
Middle East Fertility Society Journal (2024)
-
Sexual Function in Chinese Women with Polycystic Ovary Syndrome and Correlation with Clinical and Biochemical Characteristics
Reproductive Sciences (2021)
-
Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis
Hormones (2020)
-
From Table to Bedroom: Nutritional Status, Dietary Interventions, and Women’s Sexual Function
Current Sexual Health Reports (2019)